AUD 0.43
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 | 1.01 Million AUD | -71.42% |
2023 | 23.51 Million AUD | 95.75% |
2022 | 12.01 Million AUD | 34.83% |
2021 | 8.9 Million AUD | -42.64% |
2020 | 15.52 Million AUD | 331.94% |
2019 | 3.59 Million AUD | 150.55% |
2018 | 1.43 Million AUD | 1071.0% |
2017 | 122.54 Thousand AUD | 0.0% |
2016 | - AUD | 0.0% |
2015 | - AUD | 0.0% |
2014 | - AUD | 0.0% |
2013 | - AUD | 0.0% |
2012 | - AUD | 0.0% |
2011 | - AUD | -100.0% |
2010 | 6314.00 AUD | 0.0% |
2009 | - AUD | 0.0% |
2008 | - AUD | -100.0% |
2007 | 91.77 Thousand AUD | -63.42% |
2006 | 250.87 Thousand AUD | -39.07% |
2005 | 411.75 Thousand AUD | 0.0% |
2004 | - AUD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q4 | 1.01 Million AUD | 0.0% |
2024 FY | 6.71 Million AUD | -71.42% |
2024 Q2 | 18.53 Million AUD | 0.0% |
2023 FY | 23.51 Million AUD | 95.75% |
2023 Q4 | 23.51 Million AUD | 0.0% |
2023 Q2 | 22.97 Million AUD | 0.0% |
2022 Q4 | 12.01 Million AUD | 0.0% |
2022 Q2 | 8.17 Million AUD | 0.0% |
2022 FY | 12.01 Million AUD | 34.83% |
2021 FY | 8.9 Million AUD | -42.64% |
2021 Q2 | 9.65 Million AUD | 0.0% |
2021 Q4 | 8.9 Million AUD | 0.0% |
2020 Q2 | 10.46 Million AUD | 0.0% |
2020 Q4 | 15.52 Million AUD | 0.0% |
2020 FY | 15.52 Million AUD | 331.94% |
2019 Q4 | 3.59 Million AUD | 0.0% |
2019 Q2 | 1.06 Million AUD | 0.0% |
2019 FY | 3.59 Million AUD | 150.55% |
2018 Q2 | 675.53 Thousand AUD | 0.0% |
2018 FY | 1.43 Million AUD | 1071.0% |
2018 Q4 | 1.43 Million AUD | 0.0% |
2017 Q4 | 53.25 Thousand AUD | 0.0% |
2017 Q2 | - AUD | 0.0% |
2017 FY | 122.54 Thousand AUD | 0.0% |
2016 Q4 | - AUD | 0.0% |
2016 FY | - AUD | 0.0% |
2016 Q2 | - AUD | 0.0% |
2015 FY | - AUD | 0.0% |
2015 Q2 | - AUD | 0.0% |
2015 Q4 | - AUD | 0.0% |
2014 Q2 | - AUD | 0.0% |
2014 Q4 | - AUD | 0.0% |
2014 FY | - AUD | 0.0% |
2013 FY | - AUD | 0.0% |
2013 Q2 | - AUD | 0.0% |
2013 Q4 | - AUD | 0.0% |
2012 Q4 | - AUD | 0.0% |
2012 FY | - AUD | 0.0% |
2011 Q4 | - AUD | 0.0% |
2011 FY | - AUD | -100.0% |
2010 FY | 6314.00 AUD | 0.0% |
2010 Q4 | - AUD | 0.0% |
2009 FY | - AUD | 0.0% |
2009 Q4 | - AUD | 0.0% |
2008 FY | - AUD | -100.0% |
2008 Q4 | - AUD | 0.0% |
2007 Q4 | 91.77 Thousand AUD | 0.0% |
2007 FY | 91.77 Thousand AUD | -63.42% |
2006 FY | 250.87 Thousand AUD | -39.07% |
2006 Q4 | 250.87 Thousand AUD | 0.0% |
2005 FY | 411.75 Thousand AUD | 0.0% |
2005 Q4 | 411.75 Thousand AUD | 0.0% |
2004 FY | - AUD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
4DMedical Limited | 5.12 Million AUD | 80.158% |
Adherium Limited | 93.2 Thousand AUD | -990.084% |
Aroa Biosurgery Limited | 6.81 Million AUD | 85.095% |
Atomo Diagnostics Limited | 84.67 Thousand AUD | -1099.968% |
Anteris Technologies Ltd | 2.33 Million AUD | 56.449% |
Control Bionics Limited | 961.73 Thousand AUD | -5.643% |
CardieX Limited | 3.22 Million AUD | 68.523% |
Compumedics Limited | 6.97 Million AUD | 85.438% |
Cochlear Limited | 243.7 Million AUD | 99.583% |
CleanSpace Holdings Limited | 3.44 Million AUD | 70.519% |
Cyclopharm Limited | 4.22 Million AUD | 75.965% |
EMVision Medical Devices Ltd | 2.9 Million AUD | 64.969% |
Nova Eye Medical Limited | 3.34 Million AUD | 69.662% |
HeraMED Limited | 260.65 Thousand AUD | -289.791% |
Imricor Medical Systems, Inc. | 15.7 Million AUD | 93.529% |
ImpediMed Limited | 1.14 Million AUD | 11.11% |
InhaleRx Limited | 560.27 Thousand AUD | -81.342% |
LBT Innovations Limited | 1.74 Million AUD | 41.709% |
Micro-X Limited | 4.05 Million AUD | 74.944% |
Neurotech International Limited | - AUD | -Infinity% |
OncoSil Medical Limited | 70.67 Thousand AUD | -1337.646% |
PolyNovo Limited | 15.38 Million AUD | 93.394% |
Respiri Limited | 1.17 Million AUD | 13.646% |
Universal Biosensors, Inc. | 4.97 Million AUD | 79.563% |
Uscom Limited | 989.27 Thousand AUD | -2.702% |
Visioneering Technologies, Inc. | 312.15 Thousand AUD | -225.482% |